Beta Blocker Intake clinical trials

Explore recruiting beta blocker intake clinical trials.

Also recruiting in Europe

Beta Blocker Intake trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Beta Blocker Intake trials by city

Beta Blocker Intake in Toronto Beta Blocker Intake in Vancouver Beta Blocker Intake in Montreal Beta Blocker Intake in Calgary Beta Blocker Intake in Edmonton Beta Blocker Intake in Ottawa Beta Blocker Intake in Winnipeg Beta Blocker Intake in Quebec City Beta Blocker Intake in Hamilton Beta Blocker Intake in Kitchener Beta Blocker Intake in London Beta Blocker Intake in Halifax Beta Blocker Intake in New York Beta Blocker Intake in Los Angeles Beta Blocker Intake in Chicago Beta Blocker Intake in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease